Article
20 Jan 2026
Canadian Private Equity Update: Positive Trends, Liquidity Options And Key Issues For GPs And LPs
AUTHORS CONTENT
Article
08 Aug 2025
The Future Of Tech: Why Canada Is The Place To Build And Stay
Article
13 Jun 2023
Navigating Against Head Winds In The Life Sciences Capital Markets
Article
28 Sep 2022
No Prospectus, No Problem: The Listed Issuer Financing Exemption Allows For Free Trading Securities Without A Prospectus
Article
08 Oct 2021
Autonomous Vehicles: Cross Jurisdictional Regulatory Perspectives
Article
12 Jul 2021
Canadian Blind Pools Heat Up The Market: SPACs, CPCs And G-Corps
Article
29 Apr 2021
Raising Financing During Turbulent Times — Debt Capital Options For Tech Companies
Article
02 Mar 2021
Should Canadian Private Companies Merge With A Special Purpose Acquisition Company?
Article
19 Oct 2020
Financement Des Technologies Médicales Au Canada : Défis Et Possibilités
Article
19 Oct 2020
Medtech Funding In Canada: Challenges And Opportunities
Article
01 Oct 2020
Le Financement En Période Difficile — Se Tourner Vers Les Marchés Publics Pour Obtenir Des Capitaux
Article
01 Oct 2020
Raising Financing During Turbulent Times — Exploring For Capital In The Public Markets
Article
28 Aug 2020
Raising Financing During Turbulent Times: The Takeaways
Article
28 Aug 2020
Le Financement En Période Difficile : Les Points À Retenir
Article
07 Apr 2020
CSA's Response To COVID-19 Disruption To Financial Market Participants
Article
28 Jan 2019
OSC Seeks Input On Ways To Reduce Regulatory Burdens
Article
20 Jul 2018
Proposed TSX Amendments to the SPAC Regime
Article
21 Jun 2018
CSA Provides Guidance On Securities Law Implications For Token Offerings
Article
21 Feb 2018
BLG Securities Law Resource: Annual Reporting & Continuous Disclosure Rules Book
Article
19 Feb 2018
Simple Agreements For Tokens ("SAFTs") And The Regulatory Risk Of ICOs And Token Sales